Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (68 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > New Super Potent Anti-Cancer Drugs.
View:
Post by wildbird1 on Jun 16, 2024 8:04am

New Super Potent Anti-Cancer Drugs.

For the new investors in TLT..In the link below(dated 2017) you will find one very good reason to buy and hold-on to some TLT shares for the long-term.

https://theralase.com/theralase-researcher-discovers-super-potent-anti-cancer-drugs/

It is said'' DrMcFarland has discovered a new generation of PDCs, that are 10 Billion times more potent in killing cancer cells than other tested PDCs(much better than TLD-1433)''
And as a bonus the low dose needed to kill cancer cells,make these Super PDC Compound safe to use on any cancer anywhere in the body(including Brain cancer).

From the last few PressReleases, we know that TLT-PDC-Compounds are easily combined with other cancer treatments(BCG, chemotherapy..etc) to boost efficacy.
You have to wonder how these new Super-PDC-Compounds(10 billions times more potent) will improve the efficacy of any existing Big Pharma cancer treatments. When the time comes ,many Big Pharma could be lining-up to sign a deal with TLT for these Super-PDC-Compound to boost the efficacy of their own existing cancer treatments.

It will be very interesting to find out when TLT will start to test these new Super-PDC-Compounds on some cancers.The low doses needed to kill cancer cells, make these Super-PDC-Compounds a perfect fit for Brain cancer(GBM).
Would be nice if part of the $10 million financing was used to start a trial with these new Super-PDC-Compound on Brain cancer.

In short...
These new TLT-Super-PDC-Compounds can be used...
1) As a super-potent first line cancer cells killer.
2) As an ''efficacy booster'' for any existing Big Pharma cancer treatments.

Thanks to DrMcFarland and TLT management the future $value of these new Super-PDC-Compounds is mind-boggling( very good reason to hold on to your TLT shares).
But first lets get BTD approval to start the ''domino effect''.
Comment by groundhemlock on Jun 17, 2024 9:41am
Yes, Buy and hold. Show me the results. Hey i am here with my spin off shares from " INTERSTAR DAYS.," Great Potential and many dreams, many hopes, yet the results to date??....
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 68 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250